Bristol-Myers Squibb SA - Camzyos 2.5 mg, Hartkapseln | | 68477 | | 01 | | Camzyos 2.5 mg | | Hartkapseln | | C01EB24 | | Mavacamten | | 25.04.2023 | | |
| Composition | mavacamtenum 2.5 mg, silica colloidalis hydrica, mannitolum, hypromellosum, carmellosum natricum conexum, magnesii stearas, Kapselhülle: gelatina, E 171, E 172 (nigrum), E 172 (rubrum), Drucktinte: lacca, propylenglycolum, kalii hydroxidum, E 172 (nigrum), ammoniae solutio concentrata, pro capsula corresp. natrium 0.525 mg. | Packungsbestandteile | | Capsules | | | | | | Active Agent | Dose |
---|
Mavacamtenum | 2.5 mg |
| BAG: Active Agent | Dose |
---|
Mavacamtenum | 2.5 mg |
| | Inactive agents | | additional_information |
---|
(Nigrum) | | | (Rubrum) | | | Ammoniae Solutio Concentrata | | | Carmellosum Natricum Conexum | | | E 171 | | color. | E 172 | | color. | Gelatina | | Kapselhülle | Hypromellosum | | | Kalii Hydroxidum | | | Lacca | | Drucktinte | Magnesii Stearas | | | Mannitol | | | Propylenglycol | | | Silica Colloidalis Hydrica | | |
| |
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
---|
001 | 28 | 1322.66 | 1454.90 | B | SL | No |
|
|